The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.10
Bid: 44.10
Ask: 45.90
Change: 0.00 (0.00%)
Spread: 1.80 (4.082%)
Open: 44.10
High: 44.10
Low: 44.10
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Renewal of Sales and Marketing Agreement

22 Aug 2017 07:00

RNS Number : 6013O
Benchmark Holdings PLC
22 August 2017
 

 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Benchmark secures renewal of key strategic sales and marketing agreement with Great Salt Lake artemia cooperative

 

Benchmark announces that its wholly owned subsidiary, INVE Aquaculture Holding BV (INVE), has successfully renewed its sales and marketing agreement with the Great Salt Lake Brine Shrimp Cooperative, Inc (GSL COOP). Under this long-term agreement, the Benchmark group maintains its rights to distribute a substantial share of the GSL COOP's harvest of artemia from the Great Salt Lake, Utah, the world's greatest source of brine shrimp, a natural live food widely used by the aquaculture industry in early stage nutrition.

 

Historically, artemia supplied under the sales and marketing agreement has represented approximately 60% of INVE's total artemia sales, and generated revenues of over £30m in 2016. The renewal of the sales and marketing agreement secures the Company long-term access to the world's top quality artemia, which, as well as providing significant revenues from direct sales, creates demand pull for INVE's portfolio of aquaculture hatchery feeds and health products.

 

Alongside continuation of the sales and marketing agreement, INVE has entered into a similarly long-term distribution agreement with the GSL COOP for INVE's current and future artemia-related products and technologies. INVE is developing a range of breakthrough artemia-related feed products, which are on track to be launched in early 2020. The distribution agreement with the GSL COOP provides Benchmark with access to additional distribution channels and customers for INVE's artemia-related products, and will contribute to growth in sales from 2020 onwards.

 

Both the sales and marketing agreement and the distribution agreement have an initial 10 year term. Under the sales and marketing agreement GSL COOP has a 5 year break clause in certain circumstances related to new product development.

 

Benchmark CEO Malcolm Pye commented:

 

"We are extremely pleased to be continuing with and building on our important relationship with the GSL COOP. The sales and marketing agreement secures long-term access to the best quality artemia available globally, from a responsibly and sustainably harvested source. Access to the GSL COOP's customer base will compliment Benchmark's existing distribution networks for its developing artemia-related product portfolio, and is expected to create significant growth in sales across the Advanced Animal Nutrition division in the years to come."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Niall Walsh / Sophie Praill / Simon Hudson

 

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 30 June 2017, Benchmark employed 951 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUUWRUPMUGP
Date   Source Headline
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
21st Apr 20207:00 amRNSDirector and Divisional Management Changes
7th Apr 20207:00 amRNSAppointment of Chief Executive Officer
2nd Apr 20207:00 amRNSCovid-19 update
31st Mar 202011:12 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSBlock Listing Six Monthly Review
18th Mar 20207:00 amRNSBlock Admission Application
16th Mar 202012:00 pmRNSDirector Dealings
12th Mar 20201:15 pmRNSResult of AGM
9th Mar 20202:01 pmRNSHolding(s) in Company
9th Mar 20201:46 pmRNSDIRECTOR DEALINGS
28th Feb 20207:00 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSQ1 Results
25th Feb 20209:43 amRNSDIRECTOR SHARE OPTIONS
21st Feb 202010:49 amRNSDirector/PDMR Shareholding
20th Feb 20204:10 pmRNSHolding(s) in Company
20th Feb 20209:15 amRNSHolding(s) in Company
17th Feb 20204:28 pmRNSResult of General Meeting and Total Voting Rights
17th Feb 20207:00 amRNSResult of Open Offer
11th Feb 20207:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
31st Jan 20207:00 amRNSTotal Voting Rights
30th Jan 20202:46 pmRNSTimetable for Placing and Open Offer
30th Jan 20207:00 amRNSPlacing and Open Offer
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20199:06 amRNSSecond Price Monitoring Extn
20th Dec 20199:00 amRNSPrice Monitoring Extension
20th Dec 20197:00 amRNSQ4 Results
20th Dec 20197:00 amRNSFull Year Results
4th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSQ4 and FY Trading Update & Notice of Results
29th Nov 20197:00 amRNSTotal Voting Rights
11th Nov 20197:00 amRNSChief Financial Officer Appointment Update
8th Nov 20197:00 amRNSInvesting in a sustainable future for aquaculture
31st Oct 20197:00 amRNSTotal Voting Rights
28th Oct 20197:00 amRNSUpdate on dissolution of JV with AquaChile
25th Oct 20198:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.